Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Evotec SE (EVO) EBITDA (2019 - 2025)

Historic EBITDA for Evotec SE (EVO) over the last 9 years, with Q3 2025 value amounting to -$52025.3.

  • Evotec SE's EBITDA fell 7881.1% to -$52025.3 in Q3 2025 from the same period last year, while for Sep 2025 it was -$152.3 million, marking a year-over-year decrease of 19216602.39%. This contributed to the annual value of -$152.3 million for FY2024, which is 28200857.59% down from last year.
  • Latest data reveals that Evotec SE reported EBITDA of -$52025.3 as of Q3 2025, which was down 7881.1% from -$152.1 million recorded in Q4 2024.
  • Evotec SE's EBITDA's 5-year high stood at $80176.4 during Q4 2021, with a 5-year trough of -$152.1 million in Q4 2024.
  • Moreover, its 5-year median value for EBITDA was $10878.3 (2023), whereas its average is -$9.5 million.
  • Per our database at Business Quant, Evotec SE's EBITDA surged by 1872.62% in 2023 and then tumbled by 28171324.86% in 2024.
  • Evotec SE's EBITDA (Quarter) stood at $80176.4 in 2021, then tumbled by 43.25% to $45503.0 in 2022, then grew by 18.73% to $54024.0 in 2023, then tumbled by 281713.25% to -$152.1 million in 2024, then surged by 99.97% to -$52025.3 in 2025.
  • Its last three reported values are -$52025.3 in Q3 2025, -$152.1 million for Q4 2024, and -$29095.1 during Q3 2024.